1. Nat Rev Drug Discov. 2017 Dec 28;17(1):78. doi: 10.1038/nrd.2017.267.

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M, O'Shea JJ.

Erratum for
    Nat Rev Drug Discov. 2017 Dec;16(12):843-862. doi: 10.1038/nrd.2017.201.

This corrects the article DOI: 10.1038/nrd.2017.201.

DOI: 10.1038/nrd.2017.267
PMCID: PMC6168198
PMID: 29282366